AMGEN AND PLEXIUM ANNOUNCE MULTI-YEAR, DRUG DISCOVERY COLLABORATION TO IDENTIFY NOVEL TARGETED PROTEIN DEGRADATION THERAPIES Market News
Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference Pharmaceutical Investing
BioHarvest Sciences Inc. to Present at BIO CEO & Investor Conference in New York City on February 14-17, 2022 Life Science Investing
Gilead Sciences Announces 2.8 Percent Increase in First Quarter 2022 Dividend Pharmaceutical Investing
Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results Pharmaceutical Investing
AbbVie Showcases Its Leadership in Research in Inflammatory Bowel Diseases with New Analyses to be Presented at the 17th Congress of European Crohn's and Colitis Organization Pharmaceutical Investing
Komo Plant Based Foods Achieves 200 Five-Star Customer Reviews Through Yotpo App on its eCommerce Platform Life Science Investing
U.S. FDA Approves New Label Update for CAR T-Cell Therapy Yescarta® Showing Prophylactic Steriod Use Improves Management of Cytokine Release Syndrome Pharmaceutical Investing